Deals, Partnering

Orexo signs respiratory disease pact with Johnson & Johnson

Posted on 03 June 2010

Tags: ,

The agreement gives J&J units Ortho-McNeil-Janssen Pharmaceuticals and Janssen Pharmaceutica licenses to two of Orexo’s advanced preclinical programmes focusing on discovering and developing small-molecule treatments for asthma, chronic obstructive pulmonary disease and other inflammatory diseases Read more at GEN

Print Friendly, PDF & Email

Leave a Reply